Component

Human triazolam plasma AUC

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. Four weeks of modafinil reduced triazolam exposure in a controlled study of 41 women; triazolam reduction exceeded the ethinyl-estradiol reduction.

    Modafinil → Human triazolam plasma AUC Recorded from sourceungraded
    Experimental context and source evidence
    evidence_access
    Primary indexed abstract checked; full methods and figures not comprehensively reviewed.
    experimental_contrast
    {"intervention": "Four weeks of modafinil", "comparator": "Baseline/control exposure", "endpoint": "Four weeks of modafinil reduced triazolam exposure in a controlled study of 41 women; triazolam reduction exceeded the ethinyl-estradiol reduction.", "effect_direction": "decrease", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.
    experimental_model
    Human pharmacokinetic trial, 41 women; drug exposure measured, not contraceptive-failure rate.
    interpretation_status
    Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.
    limitations
    Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.
    plain_language
    Four weeks of modafinil reduced triazolam exposure in a controlled study of 41 women; triazolam reduction exceeded the ethinyl-estradiol reduction.
    primary_references
    Effect of modafinil on the pharmacokinetics of ethinyl estradiol and triazolam in healthy volunteers. | 2002 | DOI 10.1067/mcp.2002.121217 | PMID 11823757 | https://pubmed.ncbi.nlm.nih.gov/11823757/
    source_locator
    Reviewed reference lines 128-128; exact primary location described in quoted passage where extracted.

    Modafinil: detailed mechanisms of action (reviewed 3 October 2026) · lines 128–128

    Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Human pharmacokinetic trial, 41 women; drug exposure measured, not contraceptive-failure rate. · Recorded from source · Recorded from source

    A separate controlled study in 41 women found greater reduction of triazolam exposure than ethinyl-estradiol exposure after four weeks of modafinil. The authors considered intestinal first-pass induction important. A shared enzyme does not imply identical effects on all substrates. The study measured pharmacokinetics, not a contraceptive-failure rate. [Ethinyl estradiol/triazolam study](https://pubmed.ncbi.nlm.nih.gov/11823757/)
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.